| New-onset diabetes and anti hypertensive drugs | |
Abstract/OtherAbstract
:
|
Observational studies have provided evidence that a consistent fraction (approximately 15-20%) of hypertensive patients displays a glucose intolerance state that may be aggravated by anti hypertensive drug regimens based on thiazide diuretics or beta-blockers. This review examines the relative and absolute diabetogenic effects of anti hypertensive drugs, by comparing the impact of 'new' (calcium antagonists, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists) versus 'old' (diuretics and beta-blockers) drugs on new-onset diabetes in recent clinical trials. Evidence is provided that compared with diuretics and beta-blockers, new-onset diabetes is less common with 'new' drugs, and that conventional antihypertensive compounds, particularly when combined together, may amplify the natural time-dependent tendency towards the development of this metabolic disease. This paper provides new insights into the potential mechanisms responsible for the phenomenon and the clinical significance of anti hypertensive drug-induced diabetes., Mancia, G; Grassi, G; Zanchetti, A, 3 |
Authors
:
|
MANCIA, GIUSEPPE (7298), GRASSI, GUIDO (7229) |
Related Documents
:
|
29632283 - General model for calculation of drug therapy costs. |
Contributors
:
|
- |
Publication Detail
:
|
Publisher : LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA Type : Articolo su rivista, Rilevanza internazionale, Articolo, Con referee, Con Impact Factor ISI, Pubblicato Format : - |
Date Detail
:
|
2008-08-27, 2008-08-27, 2006-01 |
Subject
:
|
angiotensin-converting enzyme inhibitors; angiotensin inhibitors; beta-blockers; calcium antagonists; clinical trials; diabetes; diuretics, Settore MED/09 - Medicina Interna (1451) |
Coverage
:
|
- |
Relation
:
|
JOURNAL OF HYPERTENSION, 24, 1, 3, 10, 0263-6352 |
Source
:
|
- |
Copyright Information
:
|
- |
Other Details
:
|
Languages : eng |
Export Citation
:
|
APA/MLA Format Download EndNote Download BibTex |
Previous Document: Binding sites for SiH2/Si(001): A combined ab initio, tight-binding, and classical investigation
Next Document: Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive pa...